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University Hospital, Glasgow, UKIntroduction: Ex vivo normothermic perfusion offers an alternative method of organ preservation,
allowing donor kidneys to be reanimated and evaluated prior to transplantation. Beyond preservation, it
can be used to characterize the immunological contribution of the donor kidney in isolation. Furthermore,
it has the potential to be used as an immunomodulatory strategy to manipulate donor kidneys prior to
transplantation.
Methods: Explanted porcine kidneys underwent 6 hours of perfusion. Sequential perfusate samples were
collected and leukocytes characterized via ﬂow cytometry. An inﬂammatory proﬁle was generated via
cytokine quantiﬁcation. Cell-free DNA was also determined as markers of cell death.
Results: All kidneys functioned within normal parameters and met the criteria for transplantation at the
end of perfusion. Throughout perfusion there were continuous increases in pro-inﬂammatory cytokines,
including large concentrations of interferon-g, suggesting that perfusion drives a signiﬁcant inﬂammatory
response. Increasing concentrations in cell-free DNA were also observed, suggesting cell death. During
perfusion there was a marked cellular diapedesis of T cells, B cells, natural killer (NK) cells, and monocytes
from the kidney into the circuit. Minor populations of granulocytes and macrophages were also detected.
Discussion: We demonstrate that ex vivo normothermic perfusion initiates an inﬂammatory cytokine
storm and release of mitochondrial and genomic DNA. This is likely to be responsible for immune cell
activation and mobilization into the circuit prior to transplantation. Interestingly this did not have an impact
on renal function. These data therefore suggest that normothermic perfusion can be used to immuno-
deplete and to saturate the pro-inﬂammatory capacity of donor kidneys prior to transplantation.
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CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).K idney transplantation is severely limited by ashortage of suitable donor organs. This has led to
prolonged waiting list times and subsequent high
waiting list mortality rates. In an attempt to overcome
this problem, there has been a drive to develop ex vivo
normothermic perfusion (EVNP) as a tool to evaluate
and to recondition expanded criteria donor kidneys,
with marginal function, and kidneys donated after
circulatory death. Aside from the survival beneﬁt that
EVNP has offered to patients by enabling the safespondence: James E. Fildes, The Manchester Collaborative
for Inﬂammation Research, University of Manchester, UK,
NT. E-mail: james.ﬁldes@manchester.ac.uk
ved 6 June 2016; revised 12 July 2016; accepted 30 July
published online 6 August 2016evaluation and transplantation of such organs, this
technology may also represent a novel therapy to
manipulate the donor leukocyte repertoire prior to
transplantation.1–3
Although the importance of donor-derived leuko-
cytes in the allorecognition and rejection process has
been demonstrated previously, a detailed evaluation of
the temporal kinetics of leukocyte migration from the
kidney has not been possible prior to EVNP. To date we
have a limited understanding of the natural history of
passenger leukocyte transfer from the donor kidney to
the recipient. Given that the kidney is equipped with a
sophisticated localized immune system, such data are
important. During homeostasis, the kidney remains in a
regulatory state. However, following insult, a signiﬁ-
cant immune response can occur. In severe cases ofKidney International Reports (2016) 1, 230–239
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immune response ensues. This includes local and
eventually systemic inﬂammation manifesting in a local
cytokine storm and mass cellular inﬁltrate in the
donor.4–6 Using current strategies for transplantation, it
is at this point that the inﬂamed donor kidney with
global immune activation is implanted in the recipient.
Direct presentation of alloantigens by donor antigen
presenting cells to recipient T cells occurs rapidly
following transplantation.7 The latter cells inﬁltrate the
graft, and the rejection process is initiated. These early
interactions are key to the long-term clinical outcome of
the patient, and as such warrant detailed investigation.
This studywas designed to determine the immune and
inﬂammatory contribution of the donorkidney following
reperfusion in isolation. For this purpose, we have used a
porcine model of EVNP to replicate the response of the
donor kidney to revascularization in the absence of any
contribution from a recipient immune system.
In addition, we hypothesize that mobilization and
removal of a proportion of passenger leukocytes using
EVNP may reduce graft immunogenicity prior to
transplantation, thereby reducing acute rejection and
improving clinical outcome.8
MATERIALS AND METHODS
Procurement of Donor Organs
Kidneys from 5 Landrace pigs with a mean weight of
80 kg were collected from a local abattoir. All pigs were
culled under schedule 1 of the Home Ofﬁce Scientiﬁc Act
1986 regulations. In brief, pigs were rendered
unconscious via electrical stunning followed by exsan-
guination. Approximately 3L of bloodwas collected into
a sterile receptacle containing 100 ml of normal saline
solution supplemented with 40,000 iU of unfractionated
heparin (Fannin, UK). The abdomen was opened using a
midline incision, and the kidneys were exposed and
excised. Kidneys were immediately placed on ice and
dissected, allowing inspection for lacerations or cysts. If
deemed acceptable, the renal artery and ureter were
isolated and cannulated, and 20 ml of glyceryl trinitrate
(Hameln Pharmaceuticals, Gloucestorshire, UK) was
ﬂushed through the renal artery. This was immediately
followed by 1L 4C Soltran (Soltran; Baxter Healthcare,
Thetford, UK) supplemented with 10,000 iU of unfrac-
tionated heparin at a hydrostatic pressure of 100 mmHg.
Kidneys were then submerged in Soltran and placed on
ice for a standardized static cold storage time of 2 hours.
Perfusion Circuit
The EVNP circuit consisted of an organ chamber with a
porous platform on which the kidney was placed,
allowing the renal outﬂow to drain into the reservoir.
The perfusate was re-circulated using a centrifugalKidney International Reports (2016) 1, 230–239pump, passing through a membranous oxygenator
attached to a heatercooler system to maintain the
organ at normothermia. Pressure and temperature
probes were incorporated to maintain these parameters.
EVNP Procedure
EVNP was performed using an adaption of the
currently published protocol.9
Priming
Prior to placing the kidney onto the EVNP circuit, the
system was primed with perfusate to ensure that the
circuit was de-aired. This consisted of 350 ml of Ringer’s
solution supplemented with 5% bovine serum albumin
(BSA). Approximately 500 ml of autologous, leukocyte-
depleted (Haemonetics, UK) packed red blood cells were
infused to achieve a target hematocrit of 20% to 25%.
Following re-circulation, the perfusate was further
supplemented with 13.2 mg of dexamethasone (Hameln
Pharmaceuticals), 30 ml of 10%mannitol, 20 ml of 8.4%
sodium bicarbonate and 4,000 iU of unfractionated
heparin. A syringe driver containing 20 ml of Nutriﬂex
supplemented with 14 ml of 8.4% sodium bicarbonate,
100 iU of actrapid insulin (Novo Nordisk, Denmark),
and 25 ml of 15% glucose was infused into the circuit at
a ﬂow rate of 10 ml/h. A second syringe driver con-
taining 18 ml of epoprostenol (Sandoz, Surrey, UK) and
42 ml of normal saline solution were also infused at an
initial rate of 24 ml/h. Finally, a gas mixture of 95%
oxygen and 5% carbon dioxide was supplied to the
membrane oxygenator at a ﬂow rate of approximately
0.5 L/min. A blood gas analyser was used to assess the
pO2, pCO2, and electrolyte concentrations within the
circuit, which were corrected to maintain physiological
levels. The oxygen consumption was calculated from
venous and arterial blood using the following equation:
(pO2art – pO2ven)  ﬂow / weight. Creatinine was
added to the perfusate to achieve a circulating concen-
tration of 1500 mmol/L.
Preparation for Perfusion
Once the perfusion circuit had been fully primed and
de-aired and the blood gas variables were within
physiological reference ranges, the kidneys were
removed from ice. A baseline photograph was taken to
provide a reference during perfusion so that any
structural changes in the kidney could be monitored.
Soltran residue was removed from the vasculature with
200 ml of 4C Ringer’s solution. Finally, a needle core
biopsy was obtained, and the kidney was weighed to
provide the baseline parameters.
Perfusion
Following preparation, the kidneys were connected to
the perfusion circuit via the renal artery cannula. A
pressure probe was attached to the arterial arm of the231
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artery to be measured and controlled. The initial ﬂow
rate was reduced to approximately 0.05 L/min to allow
adequate de-airing of the kidney prior to attachment
and to prevent endothelial damage due to hemodynamic
sheer stress. The ﬂow rate was then gradually increased
until the arterial pressure reached a mean of 55 mm Hg,
and the observations were recorded. At the same time,
the ureter cannula was placed into a measuring cylinder
to collect and record the urine output. The arterial
pressure was increased by 5 mm Hg every 5 minutes
until the target pressure of 75 mm Hg was achieved 20
minutes after reperfusion. At this time, the infusion of
epoprostenol was started. Observations and blood gas
analysis were routinely collected, and any changes in
the physiology were corrected. Urine output was
regularly monitored and replaced with Ringer’s solution
to maintain normal physiology and circuit volume. The
circulating perfusate temperature was set to 38C  1C
to rapidly re-warm the kidney to physiological tem-
peratures, allowing kidney function to be restored and
cellular metabolism to be re-established. The organ
chamber was covered to maintain this temperature and
to retain the humidity throughout the perfusion period.
If there was a drop in functional parameters, therapeutic
interventions were made, in line with clinical practice,
so as to maintain tissue viability and normal physiology.
The rate of epoprostenol infusion was increased in
1.6-ml/h increments for every 10% drop in renal blood
ﬂow to a maximum of 34.8 ml/h. If the response was
inadequate despite the maximum infusion, or if urine
output dropped below 10 ml/h, then a bolus of either
10% mannitol or Ringer’s solution supplemented with
5% bovine serum albumin was added. All interventions
did not exceed doses used clinically, and responses were
closely monitored to ensure that irreversible renal fail-
ure had not occurred. In all cases, kidneys were
perfused for 6 hours.
Sample Collection During EVNP
Perfusate
Prior to initiation of EVNP, 15 ml of perfusate was
collected to provide a baseline sample. Additional
samples were collected at 15 and 30 minutes, followed
by 30-minute intervals up to 3 hours of perfusion when
samples were collected hourly. At baseline, 1 hour, and
6 hours, 100 ml of perfusate was analyzed by ﬂow
cytometry. All perfusate samples were centrifuged at
2000 g for 5 minutes, and 1-ml aliquots of plasma and
whole blood were stored at 80C.
Urine
Following 15 minutes of perfusion, 5 ml of urine
was collected. Additional samples were collected at
30-minute intervals up to 3 hours of perfusion, when232samples were collected hourly. Samples were aliquoted
and stored at 80C.
DNA Extraction
DNA was extracted from plasma samples of the
perfusate using the QIAamp DNA Mini and Blood Mini
kit, according to the manufacturer’s protocol (Qiagen,
Manchester, UK).
Quantitative Polymerase Chain Reaction
All primers used for quantitative polymerase chain
reaction were designed using the Primer Express Soft-
ware v3.0.1 (Life Technologies, Paisley, UK) and their
homology assessed using BLAST. Primers (Sigma
Aldrich, Dorset, UK) were adjusted to 50nM using
nuclease-free water (Ambion, Thermo Fisher Scientiﬁc,
Waltham, MA, USA). All quantitative polymerase chain
reaction was performed using a QuantStudio 12K Flex
system (Life Technologies, Paisley, UK)with Power SYBR
green PCR master mix (Life Technologies, Paisley, UK).
Flow Cytometry
Immunophenotyping of the perfusate samples was per-
formed on a BD LSR II ﬂow cytometer (Becton Dickinson,
Oxford, UK). Leukocytes were identiﬁed and gated as
CD45þ and their viability assessed using an eﬂuor 506
viability dye (ebioscience, San Diego, CA). Following this,
a panel of antibodies was utilized to characterize T helper
cells (CD3εþCD4aþ), cytotoxic T cells (CD3εþCD8aþ),
double-positive T cells (CD3εþCD4aþCD8aþ), double-
negative T cells (CD3εþCD4a-CD8a),gdT cells (gdþ), B
cells (CD3ε-CD21þ), classicalmonocytes (CD14þCD163),
nonclassical monocytes (CD14þCD163þ), immature neu-
trophils (6D10þ2B2), mature neutrophils (6D10þ2B2þ),
mature eosinophils/basophils (6D10-2B2þ), and natural
killer cells (CD335þ). Cellswere treatedwith red blood cell
lysing solution (BD Biosciences, UK), washed, and re-
suspended in 0.3 ml of staining buffer. A 20-ml quantity
of e123count beads (eBioscience, CA, USA) were added,
and samples were analysed for 3 minutes. All gating stra-
tegies and analysis were performed using FlowJo version
10.0.6.
Luminex Analysis
The concentration of cytokines and chemokines within
the perfusatewas assessedusingplasma samples collected
at baseline, 60minutes, and 360minutes. A commercially
available porcine 13-plex magnetic bead panel (Merck
Millipore, Billerica, MA, USA) was used, following the
manufacturer’s protocol. The plate was read using a Bio-
Plex 200 system (Bio Rad, Hertfordshire, UK).
Statistical Analysis
All statistical analysis was carried out using IBM SPSS
software version 22. Data normality was determined byKidney International Reports (2016) 1, 230–239
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evaluation was performed using the ShapiroWilk test.
Changes in renal hamodynamics and biochemistry, cell
number, and cytokine and DNA concentrations were
analyzed using the general linear model or the Friedman’s
2-way analysis of variance by ranks depending on the
distribution of the data. For comparisons between RBF at
different time points, a paired t test or Wilcoxon signed
rank test was used. Data were considered signiﬁcantly
different if a P value of <0.05 was observed.
RESULTS
Changes in Renal Hemodynamics and Oxygen
Consumption During EVNP
To assess the validity of the model and the viability of
the kidneys, the functional parameters of the kidney
were determined. Urine output, mean arterial pressure,
and renal blood ﬂow (RBF) were continually recorded.Figure 1. Renal hemodynamics and oxygen consumption remain stable d
remained within acceptable ranges during perfusion. (c) Oxygen consum
Kidney International Reports (2016) 1, 230–239Intrarenal resistance was also determined by calcu-
lating the mean arterial pressure/RBF.
All kidneys were reperfused without any complica-
tions and appeared evenly perfused, with a signiﬁcant
increase in RBF between 0 and 30 minutes of perfusion
from 29.7  4.9 ml/min/100 g to 155.6  30.4 ml/min/
100 g (P ¼ 0.043). A change in RBF was observed over
the 6-hour perfusion (P < 0.001), declining after 60
minutes of perfusion, although the level remained
within physiological parameters (Figure 1a). Following a
short period of decrease, RBF stabilized with an
increasing trend following 2 hours of perfusion. Intra-
renal resistance also ﬂuctuated during perfusion
(P ¼ 0.020) but did not exceed 0.3 mm Hg/ml/min and
was inversely proportionate to the RBF (Figure 1b). The
level of oxygen consumption observed throughout the
perfusion remained high, peaking in the ﬁrst hour.
Following this, there was a slight decline that plateaueduring perfusion. (a) Renal blood ﬂow and (b) intrarenal resistance
ption was also maintained throughout the experiment.
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duration of the procedure (P ¼ 0.006) (Figure 1c).
Urine Output and Creatinine Clearance During
EVNP
All kidneys began producing urine immediately after
being connected to the circuit (Figure 2a). The average
urine production per hour was 92.03  78.13 ml, with
a mean total urine output of 530.04  243.78 ml. The
pattern of urine output changed during the perfusion
period (P ¼ 0.001), with a decline in urine output after
the ﬁrst hour of perfusion. The serum creatinine con-
centration in the circuit signiﬁcantly decreased during
the 6-hour perfusion (P < 0.001, Figure 2b).
Chemokine and Cytokine Concentrations Within
the Perfusate
To characterize the inﬂammatoryproﬁle duringperfusion,
13 cytokines and chemokines were assessed. Increasing
concentrations of interferon (IFN)g (P ¼ 0.021), inter-
leukin (IL)1a (P¼ 0.016), IL-1b (P¼ 0.010), IL-1RA (P¼
0.009), IL-2 (P ¼ 0.017), IL-6 (P < 0.001), C-X-C motif
chemokine ligand 8 (CXCL-8) (P ¼ 0.007), IL-10 (P ¼
0.007), and IL-18 (P< 0.001) were detected. This occurred
immediately following initiation of perfusion and was
maintained throughout the procedure. However gran-
ulocyte-macrophage colony-stimulating factor (GM-CSF),
IL-4, IL-12, and tumor necrosis factor (TNF)a did not
change from baseline, suggesting that EVNP drives a
signiﬁcant inﬂammatory response (Figure 3 ad).
Concentration of Circulating Cell-Free
Mitochondrial and Genomic DNA
To determine whether EVNP induces cell death
during perfusion, circulating cell-free mitochondrialFigure 2. Tubular function is restored and retained over 6 hours of perfu
zation, peaking in the ﬁrst hour of perfusion. (b) Creatinine is continually
234and genomic DNA were quantiﬁed. An increase in the
concentration of both cell-free genomic and mitochon-
drial DNA was observed (P < 0.001 and P ¼ 0.008,
respectively), suggesting that EVNP causes a degree of
cellular injury upon reperfusion (Figure 4 a and b).
Cellular Efﬂux From the Donor Kidney Into the
Perfusate
The immune cell efﬂux from the donor kidney into the
EVNP circuit was characterized to assess the contri-
bution of passenger leukocytes from the donor kidney
following transplantation (Figure 5 ad). Major pop-
ulations of donor T cells including helper, cytotoxic
double-negative, and CD4þCD8þ T cells were identi-
ﬁed within the ﬁrst 60 minutes of perfusion and
increased throughout the procedure (P ¼ 0.015,
P ¼ 0.022, P ¼ 0.012, and P ¼ 0.021, respectively).
A large population of B cells was also detected,
with the greatest number being identiﬁed following
6 hours of perfusion (P ¼ 0.041).
Of the granulocyte lineage, mature basophils and
eosinophils migrated into the circuit with an increase
in numbers during perfusion (P ¼ 0.015). Equally, the
number of mature and immature neutrophils increased
(P ¼ 0.026 and P ¼ 0.038 respectively). Classical
monocytes represented the major monocyte population,
with nonclassical monocytes being less abundant.
However, the size of both populations remained
consistent during perfusion (P ¼ 0.059 and P ¼ 0.549
for classical and nonclassical repertoires, respectively).
Minor populations of natural killer (NK) cells and
macrophages were also detected, with NK cells
observed to increase over time (P ¼ 0.015 and
P ¼ 0.449, respectively).sion. (a) Urine production began immediately following revasculari-
removed from the circuit by the kidney and excreted in the urine.
Kidney International Reports (2016) 1, 230–239
Figure 3. Cytokine secretion increases over time during ex vivo perfusion. (ad) Serial perfusate samples were analyzed by Luminex to detect a
range of cytokines and chemokines. After approximately 60 minutes on the circuit, EVNP is associated with a rapid increase in the secretion of
IFN-g, IL-1a, IL-1b, IL-1RA, IL-2, IL-6, CXCL-8, IL-10, and IL-18. The concentration of GM-CSF, IL-4, IL-12, and TNF-a remains unaffected.
(CXCL, C-X-C motif chemokine ligand; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; TNF, tumor
necrosis factor.)
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Normothermic EVNP provides unique insight into the
immunological and inﬂammatory contribution of the
donor kidney following revascularization. In this study,
EVNP resulted in a signiﬁcant inﬂammatory storm with
surprisingly high concentrations of IL-6 (80,242 
15,950 pg/ml perfusate), CXCL-8 (49,980  39 pg/ml
perfusate), and IFN-g (16,292  26917 pg/ml perfusate)
detectable at the end of perfusion. Other pro-
inﬂammatory cytokines also increased throughout the
6-hour perfusion period, including IL-1b, IL-1RA, and
IL-12. To a lesser extent, increases in IL-4, IL-10, IL-18,
and TNF-a were detected, but did not exceed 500 pg/ml
throughout perfusion. We believe that these data are ofKidney International Reports (2016) 1, 230–239importance, as they provide insight into the potential
contribution of the donor kidney to the inﬂammatory
events that occur immediately following trans-
plantation. For example, if the donor kidney drives a
similar CXCL-8 response following revascularization,
this will result in both donor and recipient cellular
mobilization and an efﬂux of cells out of the donor
kidney and into the recipient vasculature. Recipient
immune cells expressing the CXCL-8 receptors CXCR1
and CXCR2 (including dendritic cells and T cells) will
inﬁltrate the donor kidney via this CXCL-8dependent
chemokine gradient. Therefore the CXCL-8 response
could contribute to the diapedesis of donor leukocytes
to recipient lymph nodes, and the recruitment of
recipient dendritic cells and T cells to the graft. As235
Figure 4. Ex vivo normothermic perfusion is associated with increasing concentrations of (a) cell-free genomic DNA and (b) mitochondrial DNA.
Cell-free mitochondrial and genomic DNA concentrations from plasma samples were quantified using quantitative polymerase chain reaction.
Increasing concentrations are detected during perfusion, suggesting cellular injury occurs.
CLINICAL RESEARCH JP Stone et al.: Reduced Immunogenicity via EVNPrecipient T cells inﬁltrate the graft they encounter
alloantigen presented directly via donor dendritic cells,
which self-present donor leukocyte antigens or donor
peptides. Inﬁltrating recipient dendritic cells also pro-
cess and present donor peptides to recipient T cells,
which collectively represent the hallmark of allor-
ecognition and ultimately lead to permanent T-cell
alloreactivity.10 IL-6 is an acute-phase cytokine that
plays a central role in ischemia-reperfusion injury and
contributes to graft rejection by orchestrating leukocyte
recruitment, activation, and proliferation of a range of
lymphocytes.11,12 IL-6 pathway inhibitors have subse-
quently been used following transplantation and have
shown promise in improving early graft survival. Given
the profoundly high levels observed in our study, the
donor kidney may represent a major source of IL-6
following transplantation and as such may represent a
therapeutic target. We also observed high levels of IFN-
g, which is a major pro-inﬂammatory cytokine involved
in allorecognition and alloreactivity. IFN-g induces the
up-regulation of class I major histocompatibility com-
plex on graft epithelial and endothelial cells and drives
recipient leukocyte inﬁltration of the donor kidney.13,14
However, as EVNP is a closed system, IL-6, CXCL-8, and
IFN-g are released prior to transplantation and had no
adverse effect on renal function during perfusion.
Instead, the pro-inﬂammatory cytokine response
observed may be responsible for the activation and
mobilization of donor-derived leukocytes out of the
donor kidney during perfusion. Furthermore, inducing
the secretion of IL-6, CXCL-8, and IFN-g may exhaust
the pro-inﬂammatory response of the donor kidney236prior to transplantation, and may also impede the
ability of donor cells to respond in the post-
transplantation setting. As such, the presence of these
cytokines may be reduced following transplantation,
thereby inhibiting their deleterious effects and pro-
moting graft survival.
From the current study it is not possible to decipher
the cytokine source; however, increasing concentra-
tions of mitochondrial and genomic DNA were detected
throughout perfusion. This is likely as a result of a loss
of leukocyte viability within the circuit due to the
interaction of these cells with the plastic circuit, as well
as the inventible ischemia-reperfusion injury that en-
sues. The release of endogenous damage-associated
molecular patterns such as extracellular DNA are asso-
ciated with the initiation and maintenance of a pro-
inﬂammatory response and immune activation.15
Although this may partly explain the increase in a
range of cytokines, the EVNP circuit itself may inﬂu-
ence the inﬂammatory response, as it consists of a
modiﬁed cardiopulmonary bypass machine. It is well
documented that patients placed on cardiopulmonary
bypass during surgical procedures develop systemic
inﬂammatory response syndrome (SIRS).16 This is pro-
posed to be due to the interaction of leukocytes with an
artiﬁcial surface, leading to cellular activation and
resultant cytokine secretion.17 Interestingly, this does
not appear to inﬂuence clinical outcome. Indeed, in our
study, kidney function was maintained throughout
perfusion despite increasing cytokine and extracellular
DNA concentrations. All kidneys functioned within
normal parameters, remained biochemically stable, andKidney International Reports (2016) 1, 230–239
Figure 5. Donor leukocytes migrate out of the kidney into the perfusate during ex vivo normothermic perfusion. Serial perfusate samples were
analyzed by flow cytometry to identify migrating leukocytes. Large populations of T cells, B cells (a), and NK cells (b) were detected in
increasing concentrations during the perfusion period. Populations of monocytes, macrophages (c), neutrophils and basophils and eosinophils
(d) were also detected.
JP Stone et al.: Reduced Immunogenicity via EVNP CLINICAL RESEARCHmet the criteria for transplantation throughout perfu-
sion.18 Urine production began immediately and
continued for the duration of the perfusion, although a
decline was observed after 1 hour. Following an
ischemic insult and subsequent development of acute
tubular necrosis, a polyuric phase is often observed that
can then stabilize when tubular function is restored.19
We propose that the initial large volume of urine is
reﬂective of acute tubular injury that stabilizes during
reperfusion and adequate oxygenation. In corroborationKidney International Reports (2016) 1, 230–239of this, acidbase balance was maintained, suggesting
that tubular function remained viable. Interestingly, an
increase in lactate concentration was observed, which
can be an indicator of regional ischemia and hypo-
perfusion. In a clinical setting, it is widely considered
that a lactate concentration above 4 mmol/L is associ-
ated with poorer patient outcomes.20,21 During this
study, the mean lactate concentration did not exceed
2.5 mmol/L and was therefore unlikely to be represen-
tative of impaired kidney function. However, it is237
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hours of static cold storage to minimize the ischemic
injury, thereby providing a clear indication of the
inﬂammatory capacity of the donor organ. Prolonged
ischemic times may inﬂuence the inﬂammatory proﬁle
described as a result of tissue injury.
Aside from cytokine secretion in the presence of
good renal function, we also demonstrate that the kid-
ney contains a large reservoir of leukocytes that rapidly
mobilize following revascularization. Major populations
of donor leukocytes were detected in the perfusate as
early as 60 minutes postperfusion, suggesting that these
cells are marginal and can extravasate from the tissue
and enter the recipient circulation following trans-
plantation. This includes large populations of T cells
(4,154,908  1,894,451 cells/ml perfusate) and B cells
(376,098  275,830 cells/ml perfusate) that have the
capacity to drive inﬂammation, secrete pro-
inﬂammatory cytokines (including IL-6, CXCL-8, and
IFN-g), and orchestrate alloantigen-speciﬁc immune
responses. Ultimately this can lead to acute rejection
and graft loss. It should be noted that within this T cell
population, a proportion may be of regulatory pheno-
type, although this was not determined in this study.
Removing these cells prior to transplantation may have
a negative impact on clinical outcomes via a loss of
tolerance induction. However, we propose that a sig-
niﬁcant proportion of these cells are unlikely, given the
predominantly inﬂammatory environment. Signiﬁcant
numbers of NK cells were also observed within the
perfusate (124,644  109,934 cells/ml perfusate). NK
cells have multiple functions and can secrete high levels
of IL-6, CXCL-8, and IFN-g upon stimulation. They are
also central in the recruitment of cytotoxic T cells
during inﬂammation, which are recruited into the
kidney and contribute to tissue destruction and a loss of
graft function. The diapedesis of major populations of
cells with antigen-presenting capacity also occurred,
including monocytes, macrophages, and B cells. These
donor leukocytes are essential for direct presentation
and can provide co-stimulatory signals to recipient T
cells.22
A porcine model was used in this study because of
the similarity in physiology and organ development to
those of humans.23 The pigs used were a size similar to
that of humans, and all pigs were the same breed and
size. In addition, the mode of death was standardized to
minimize data variation. However, it should be noted
that using abattoir animals is not without limitations,
as these animals are from an uncontrolled environment,
although this is more reﬂective of a heterogeneous
population.238Although the fate of the immune efﬂux cannot be
determined in this study, we propose that the migra-
tion of billions of donor leukocytes in conjunction with
the secretion of an IFN-g, IL-6, and CXCL-8 storm
would drive direct allorecognition and would orches-
trate signiﬁcant recipient immune activation following
transplantation. Furthermore, a major proportion of
these donor leukocytes are likely to home to lymph
nodes and self-present donor antigens to naive recip-
ient T cells.24 Removing this inﬂammatory burden
prior to transplantation may therefore confer signiﬁ-
cant clinical beneﬁt.8 Based on our ﬁndings, we now
believe that immunomodulatory strategies to alter the
donor immune environment prior to transplantation
warrant development.
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